NeuBase Therapeutics to Present at the LD Micro Conference
June 05, 2019 09:55 ET
|
NeuBase Therapeutics, Inc.
PITTSBURGH, June 05, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (“NeuBase”), a biotechnology company developing next generation antisense therapies to address genetic diseases, announced...
NeuBase Therapeutics Designates Industry Leaders to Board of Directors
May 16, 2019 08:00 ET
|
NeuBase Therapeutics, Inc.
PITTSBURGH, May 16, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (“NeuBase”), a biotechnology company developing next generation antisense therapies to address genetic diseases, today...
NeuBase Therapeutics Announces Agreements for $9 Million Financing
March 11, 2019 07:00 ET
|
NeuBase Therapeutics, Inc.
PITTBURGH, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (“NeuBase”), a biotechnology company developing next generation antisense therapies to address rare genetic diseases,...